DeepScribe vs Suki
This pairing separates two different ideas of what comes after the scribe. DeepScribe went deep: built for complex specialty medicine with oncology as its center of gravity, a reported 5 million oncology visits a year and roughly 40 percent of US cancer care visits documented on the platform, holding a 98.8 KLAS Emerging Company Spotlight score with A plus marks in all six categories, the highest independent rating in the lane. Suki went interactive: a voice first assistant where ambient capture sits alongside commands that operate the EHR itself, ordering medications, navigating charts, querying the record, and staging orders for review, across deep bidirectional integrations from Epic to MEDITECH. If your failure mode is specialty documentation that generic scribes get wrong, oncology above all, start with DeepScribe. If your failure mode is the clicks around the note rather than the note itself, start with Suki. Neither publishes pricing.
- Specialty depth is the requirement: tuned models for oncology, cardiology, urology, gastroenterology, orthopedics, neurology, and nephrology, with a reported 40 percent of US cancer care visits documented on the platform.
- The independent rating is the strongest in the lane: a 98.8 KLAS Emerging Company Spotlight score with A plus marks across all six measured categories, plus 2025 KLAS Top 5 rankings for outcomes, patient experience, and clinician experience.
- Chart aware in both directions: bidirectional integration with Epic, athenahealth, NextGen, and eClinicalWorks reads context before the visit and writes structured data into discrete fields after, with HCC, CPT, and ICD-10 suggestions built into the note.
- You want to operate the EHR by voice, not just document: commands order medications, navigate charts, query the patient record, stage orders for review, and pull schedules, which no passive scribe does.
- EHR reach across mixed estates: deep bidirectional integrations with Epic, Oracle Health, athenahealth, MEDITECH, and Elation, plus a partnership program extending to further systems.
- You build healthcare software: Suki Platform lets other vendors embed the voice and ambient capabilities inside their own products, an option unique in this pairing.
Side-by-Side
| Axis | D DeepScribe |
S Suki |
|---|---|---|
| AI Centrality | ||
| Autonomy and Oversight Model | — | |
| Model and Technology Transparency | — | — |
| Clinical and Operational Evidence | — | |
| AI Safety and PHI Stewardship | — | |
| HIPAA and BAA Posture | — | — |
| Security Certifications and Trust Center | — | — |
| FDA and Regulatory Status | — | — |
| AI Governance and Bias Disclosure | — | — |
| EHR and Interoperability Depth | ||
| Deployment Model and Data Residency | — | — |
| Commercial Transparency | ||
| Setting and Specialty Coverage | — |
Visit volumes and market share figures are vendor published, including DeepScribe's oncology share and Suki's weekly consult count. DeepScribe's KLAS scores are buyer survey based; the Emerging Company Spotlight is a different KLAS instrument from the Best in KLAS category awards held elsewhere in this lane. Suki deletes audio and transcripts after 30 days by default. Neither vendor publishes pricing.